Back to RecallTracker
Health Canada Health products

Taro-Doxorubicin Liposomal: may contain particulate matter

Issued July 11, 2025
Issue
Affected lot may contain the presence of particulate matter.
Hazard description
Product quality
What to do
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
Product
Product name
Taro-Doxorubicin Liposomal
Reference
ID
RA-77723